Adalimumab/certolizumab-pegol/golimumab

  • PDF / 169,006 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 41 Downloads / 164 Views

DOWNLOAD

REPORT

1 S

Uveitis flare up: case reports. In an observational single center study including 320 patients, a patient [age and sex not stated] was described, who developed uveitis flare up during treatment with adalimumab, certolizumab-pegol and golimumab for psoriatic arthritis. The patient with psoriatic arthritis was enrolled in the study. The patient had several recurrent episodes of uveitis. The patient developed new flares during treatment with adalimumab, certolizumab-pegol [certolizumab] and golimumab [routes, dosages, duration of treatments to reaction onset and outcome not stated]. Gonzalez-Mazon I, et al. Epidemiology, clinical features and biological treatment of uveitis in 320 patients with psoriatic arthritis. study from a single university center. 803516343 Annals of the Rheumatic Diseases 79 (Suppl. 1): 1686-1687, Jun 2020. Available from: URL: https://ard.bmj.com/content/79/Suppl_1/1686.2 [abstract]

0114-9954/20/1831-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 21 Nov 2020 No. 1831

Data Loading...